Thymoglobulin: all 116 studies that test it
Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaRecruitingNCT07257419Phase 1
- Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated DonorRecruitingNCT06083129Phase 3
- PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUMNot yet recruitingNCT06066255Phase 2
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingNCT05736419Phase 2
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesRecruitingNCT05735717Phase 2
- Haploidentical HCT for Severe Aplastic AnemiaRecruitingNCT04558736Phase 2
- Stem Cell Transplantation in Crohn's DiseaseRecruitingNCT04224558Phase 1/2
- Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity ConditioningRecruitingNCT03852407Phase 2
- The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant RecipientsEnrolling by invitationNCT03292861Phase 2
- Autologous Stem Cell Transplant for Crohn's DiseaseRecruitingNCT03219359Phase 2
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaRecruitingNCT01949129Phase 2/3
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsTerminatedNCT04530487Phase 2Results posted
- Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic AnemiaCompletedNCT04328727Phase 2Results posted
- Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant RecipientsCompletedNCT03663335Phase 2Results posted
- Cardiac Safe Transplants for Systemic SclerosisTerminatedNCT03593902Phase 2/3Results posted
- Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)CompletedNCT03263559Phase 2Results posted
- Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsTerminatedNCT02877082Phase 2Results posted
- NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic AnemiaCompletedNCT02833805Phase 2Results posted
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)CompletedNCT02766465Phase 2Results posted
- A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver TransplantationCompletedNCT02544113Phase 2Results posted
- Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal TransplantCompletedNCT02464878Phase 2Results posted
- Stem Cell Transplantation for Stiff Person Syndrome (SPS)TerminatedNCT02282514Phase 1/2Results posted
- Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic AnemiaCompletedNCT02224872Phase 2Results posted
- Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)TerminatedNCT02080195Phase 1/2Results posted
- Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive RegimenTerminatedNCT01856257Phase 2Results posted
- Non-Myeloablative Conditioning and Bone Marrow TransplantationActive, not recruitingNCT01850108Not applicableResults posted
- Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationCompletedNCT01810588Phase 2Results posted
- Belatacept Early Steroid Withdrawal TrialCompletedNCT01729494Phase 4Results posted
- Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney TransplantationTerminatedNCT01517984Phase 2Results posted
- Low Dose Thymoglobin in Renal Transplant PatientsCompletedNCT01280617Not applicableResults posted
- Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCTCompletedNCT01246206Phase 2Results posted
- Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell TransplantsTerminatedNCT01135537Phase 2Results posted
- Reversing Type 1 Diabetes After it is EstablishedCompletedNCT01106157Phase 1/2Results posted
- Low Dose Thymoglobulin to Protect Kidney Function After Liver TransplantCompletedNCT00970073Not applicableResults posted
- Combined Haploidentical-Cord Blood Transplantation for Adults and ChildrenCompletedNCT00943800Not applicableResults posted
- Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney TransplantationCompletedNCT00906204Phase 2Results posted
- Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATGCompletedNCT00899847Phase 2Results posted
- Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor AntagonistsCompletedNCT00859131Not applicableResults posted
- Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and ThymoglobulinCompletedNCT00822770Phase 1/2Results posted
- Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic SyndromeCompletedNCT00806598Phase 2Results posted
- Double Cord Blood Transplant for Patients With Malignant and Non-malignant DisordersTerminatedNCT00801931Phase 1/2Results posted
- Hematopoietic Stem Cell Transplant in Devic's DiseaseCompletedNCT00787722Phase 1/2Results posted
- Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant RecipientsCompletedNCT00771745Phase 4Results posted
- Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCTCompletedNCT00709592Phase 2Results posted
- Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic TransplantationTerminatedNCT00593645Phase 2Results posted
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesCompletedNCT00566696Phase 2Results posted
- Improved Induction and Maintenance Immunosuppression in Kidney TransplantationCompletedNCT00556933Phase 4Results posted
- Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic SyndromeTerminatedNCT00542828Phase 2Results posted
- Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)TerminatedNCT00506948Phase 2Results posted
- Allogeneic Transplantation in Patients With Cutaneous T-Cell LymphomaCompletedNCT00506129Phase 2Results posted
- Thymoglobulin and Total Lymphoid Irradiation for Hematologic MalignanciesCompletedNCT00476229Not applicableResults posted
- Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic AnaemiaCompletedNCT00471848Phase 2Results posted
- Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenCompletedNCT00448357Phase 1/2Results posted
- Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive CrossmatchCompletedNCT00275509Phase 3Results posted
- Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
- EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionCompletedNCT00105183Phase 3Results posted
- Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaCompletedNCT00065260Phase 2Results posted
- Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant DiseasesCompletedNCT00038857Phase 2Results posted
- Sirolimus and Thymoglobulin to Prevent Kidney Transplant RejectionCompletedNCT00006178Phase 2Results posted
- A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)TerminatedNCT05600426Phase 3
- Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic DisordersWithdrawnNCT05293509Phase 2
- Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCTStatus unknownNCT05214066Phase 2
- Antithymocyte Globulin as a Second Line Therapy in Graves OrbitopathyStatus unknownNCT05199103Not applicable
- Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)Active, not recruitingNCT04936282Phase 4
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe HemoglobinopathiesWithdrawnNCT04776850Early Phase 1
- A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological MalignanciesActive, not recruitingNCT04547049Phase 3
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)CompletedNCT04509791Phase 2
- Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)CompletedNCT04114188Phase 2
- Autologous Transplant To End NMO Spectrum DisorderWithdrawnNCT03829566Phase 2/3
- Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney TransplantationStatus unknownNCT03789006Phase 4
- Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant RecipientsStatus unknownNCT03470961Phase 4
- Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorStatus unknownNCT03171831Phase 4
- A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney TransplantCompletedNCT03099122Phase 4
- Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive RegimenStatus unknownNCT03088280Phase 4
- Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant PatientsCompletedNCT03006419Phase 4
- Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic AnemiaCompletedNCT02845596Not applicable
- Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCTTerminatedNCT02627573Phase 2
- Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)Status unknownNCT02447822Phase 4
- A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic AnemiaCompletedNCT02203396Phase 2
- Single Dose rATG for Renal Allograft RejectionStatus unknownNCT02102854Phase 4
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaStatus unknownNCT02028416Not applicable
- Preemptive Therapy of GVHDTerminatedNCT01994824Phase 2
- Thymoglobulin in Cadaver DonorCompletedNCT01939171Phase 2
- Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAAStatus unknownNCT01844635Phase 3
- De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab InductionTerminatedNCT01312064Phase 4
- Thymoglobulin in Unrelated Hematopoietic Progenitor Cell TransplantationStatus unknownNCT01217723Phase 3
- A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)WithdrawnNCT01157949Phase 3
- Attenuating Ischemia Reperfusion Injury After Living Donor Renal TransplantationWithdrawnNCT01149993Phase 4
- Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic AnemiaWithdrawnNCT01129323Not applicable
- Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal TransplantationCompletedNCT01046955Phase 4
- mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal TransplantationCompletedNCT01028092Phase 3
- Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant DiseasesCompletedNCT01019876Phase 2/3
- Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell TransplantationStatus unknownNCT00934557Phase 3
- Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AMLStatus unknownNCT00887042Phase 1/2
- Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)CompletedNCT00885833Phase 1/2
- Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)Status unknownNCT00882323Phase 2
- Comparison of ATG to Thymoglobuline in Renal TransplantationCompletedNCT00861536Phase 4
- Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT00750126Phase 2
- Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)Status unknownNCT00737685Phase 2